Document is current
Any future updates will be listed below
-
Authors
Shen, Tao http://orcid.org/0000-0002-6129-3092
Hu, Zhihang
Sun, Siqi http://orcid.org/0000-0001-7240-8724
Liu, Di http://orcid.org/0000-0002-0708-7466
Wong, Felix
Wang, Jiuming http://orcid.org/0009-0003-9591-156X
Chen, Jiayang
Wang, Yixuan
Hong, Liang
Xiao, Jin http://orcid.org/0000-0001-5059-1492
Zheng, Liangzhen
Krishnamoorthi, Tejas
King, Irwin
Wang, Sheng http://orcid.org/0000-0003-4210-1670
Yin, Peng http://orcid.org/0000-0002-2769-6357
Collins, James J. http://orcid.org/0000-0002-5560-8246
-
Funding
Funding for this research was provided by:
Research Grants Council, University Grants Committee (24204023)
Innovation and Technology Fund (GHP/065/21SZ)
- License Information
-
More Information
Article History
Received: 31 January 2024
Accepted: 25 September 2024
First Online: 21 November 2024
Competing interests
: S.W. and L.Z. are the co-founders of Zelixir Biotech Co. Ltd. P.Y. is a co-founder, equity holder, board member and consultant of Ultivue, Inc., Spear Bio, Inc. and Digital Biology, Inc. J.J.C. is the founding scientific advisory board chair of Integrated Biosciences. F.W. is a co-founder of Integrated Biosciences. The other authors declare no competing interests.
